Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2012 ∙ Demicheli, V. Rivetti, A. Debalini, M. G. Di Pietrantonj, C.

Vaccines for measles, mumps and rubella in children

  • Newborn
  • Children
  • Adolescents
  • Mumps
  • Measles
  • Rubella
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
High
2012 ∙ Jefferson, T. Rivetti, A. Di Pietrantonj, C. Demicheli, V. Ferroni, E.

Vaccines for preventing influenza in healthy children

  • Newborn
  • Children
  • Adolescents
  • Influenza
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2011 ∙ Young, F. Marra, F.

A systematic review of intradermal influenza vaccines

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2011 ∙ Michiels, B. Govaerts, F. Remmen, R. Vermeire, E. Coenen, S.

A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups

  • All age groups
  • Pregnant women
  • Healthcare workers
  • Influenza
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2011 ∙ Nguyen, T. Henningsen, K. H. Brehaut, J. C. Hoe, E. Wilson, K.

Acceptance of a pandemic influenza vaccine: A systematic review of surveys of the general public

  • All age groups
  • Influenza
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2011 ∙ Thomas, R. E. Lorenzetti, D. L. Spragins, W. Jackson, D. Williamson, T.

Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic review

  • All age groups
  • Yellow fever
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2011 ∙ Higginson, D. Theodoratou, E. Nair, H. Huda, T. Zgaga, L. Jadhav, S. S. Omer, S. B. Rudan, I. Campbell, H.

An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children

  • Newborn
  • Children
  • Adolescents
  • Measles
  • Acceptance
  • Efficacy/effectiveness
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2011 ∙ Glenton, C. Scheel, I. B. Lewin, S. Swingler, G. H.

Can lay health workers increase the uptake of childhood immunisation? Systematic review and typology

  • Newborn
  • Children
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2011 ∙ Martin-Hirsch, P. L. Wood, N. J.

Cervical cancer

  • All age groups
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2011 ∙ Scott, P. Rutjes, A. W. S. Bermetz, L. Robert, N. Scott, S. Lourenço, T. Egger, M. Low, N.

Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: Systematic review and meta-analysis

  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...